EU signs contract with AstraZeneca on supply of potential COVID-19 vaccine
BRUSSELS, Aug 27 (Reuters) - The European Commission said on Thursday it had signed a contract on behalf of EU states with British drugmaker AstraZeneca AZN.L for the supply of at least 300 million doses of its COVID-19 vaccine candidate.
The move follows an advance purchase agreement signed by Brussels with AstraZeneca earlier in August.
It is the first contract signed by the EU with a maker of potential COVID-19 vaccines. The contract envisages an option to purchase 100 million additional doses to be distributed on a population-based pro-rata basis among the 27 EU states.
(Reporting by Francesco Guarascio @fraguarascio; Editing by Hugh Lawson)
((Francesco.Guarascio@thomsonreuters.com; +32 2 287 68 17;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.